Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 2
2008 1
2009 1
2010 3
2011 3
2013 4
2015 2
2016 4
2017 9
2018 13
2019 8
2020 5
2021 11
2022 8
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Cholangiocarcinoma.
Sarcognato S, Sacchi D, Fassan M, Fabris L, Cadamuro M, Zanus G, Cataldo I, Capelli P, Baciorri F, Cacciatore M, Guido M. Sarcognato S, et al. Among authors: cadamuro m. Pathologica. 2021 Jun;113(3):158-169. doi: 10.32074/1591-951X-252. Pathologica. 2021. PMID: 34294934 Free PMC article. Review.
Necroptosis in Cholangiocarcinoma.
Sarcognato S, Jong IEM, Fabris L, Cadamuro M, Guido M. Sarcognato S, et al. Among authors: cadamuro m. Cells. 2020 Apr 15;9(4):982. doi: 10.3390/cells9040982. Cells. 2020. PMID: 32326539 Free PMC article. Review.
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
Cadamuro M, Brivio S, Mertens J, Vismara M, Moncsek A, Milani C, Fingas C, Cristina Malerba M, Nardo G, Dall'Olmo L, Milani E, Mariotti V, Stecca T, Massani M, Spirli C, Fiorotto R, Indraccolo S, Strazzabosco M, Fabris L. Cadamuro M, et al. J Hepatol. 2019 Apr;70(4):700-709. doi: 10.1016/j.jhep.2018.12.004. Epub 2018 Dec 14. J Hepatol. 2019. PMID: 30553841 Free PMC article.
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance.
Calvisi DF, Boulter L, Vaquero J, Saborowski A, Fabris L, Rodrigues PM, Coulouarn C, Castro RE, Segatto O, Raggi C, van der Laan LJW, Carpino G, Goeppert B, Roessler S, Kendall TJ, Evert M, Gonzalez-Sanchez E, Valle JW, Vogel A, Bridgewater J, Borad MJ, Gores GJ, Roberts LR, Marin JJG, Andersen JB, Alvaro D, Forner A, Banales JM, Cardinale V, Macias RIR, Vicent S, Chen X, Braconi C, Verstegen MMA, Fouassier L; CCA Model Consortium. Calvisi DF, et al. Nat Rev Gastroenterol Hepatol. 2023 Jul;20(7):462-480. doi: 10.1038/s41575-022-00739-y. Epub 2023 Feb 8. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36755084 Free article. Review.
Precision medicine in cholangiocarcinoma.
Pellino A, Loupakis F, Cadamuro M, Dadduzio V, Fassan M, Guido M, Cillo U, Indraccolo S, Fabris L. Pellino A, et al. Among authors: cadamuro m. Transl Gastroenterol Hepatol. 2018 Jul 12;3:40. doi: 10.21037/tgh.2018.07.02. eCollection 2018. Transl Gastroenterol Hepatol. 2018. PMID: 30148225 Free PMC article. Review.
Diagnostic and prognostic biomarkers in cholangiocarcinoma.
Macias RIR, Kornek M, Rodrigues PM, Paiva NA, Castro RE, Urban S, Pereira SP, Cadamuro M, Rupp C, Loosen SH, Luedde T, Banales JM. Macias RIR, et al. Among authors: cadamuro m. Liver Int. 2019 May;39 Suppl 1:108-122. doi: 10.1111/liv.14090. Liver Int. 2019. PMID: 30843325 Review.
74 results